Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Presentation TCT 2019

PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Vinod Thourani

September 28, 2019

Presentation TCT 2019

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Presenter: Raj Makkar

September 27, 2019

Presentation TCT 2019

Industry Perspective on Drug-Eluting Technologies Guidance

Presenter: Mark Pacyna

September 25, 2019

Presentation TCT 2019

FDA Perspective and Revised Guidance

Presenter: Eleni Whatley

September 25, 2019

Presentation TCT 2019

New Data Regarding Drug-Eluting Technologies

Presenter: Krishna Rocha-Singh

September 25, 2019

Presentation TCT 2019

An Unforeseen Setback: Summary Level Meta-Analysis Brings Practice Back to the 1990s.

Presenter: Michael Jaff

September 25, 2019

Presentation TCT 2019

Complex CLI Case Review 3: What Is Possible in the OBL?

Presenter: Eric Dippel

September 25, 2019

Presentation TCT 2019

Complex CLI Case Review 2: My Toughest Case From the Last Year

Presenter: Peter Soukas

September 25, 2019

Presentation TCT 2019

Complex CLI Case Review 1: My Best Case From the Last Year

Presenter: Venita Chandra

September 25, 2019

Presentation TCT 2019

CLI Diagnostics and Real-Time Guidance: What's New in 2019

Presenter: Matthew Menard

September 25, 2019

Presentation TCT 2019

Clinical Trial Updates: BTK Tacks, Scaffolds, and Drugs

Presenter: Ehrin Armstrong

September 25, 2019

Presentation TCT 2019

Clinical Trial Updates: Deep Vein Arterialization

Presenter: Steven Kum

September 25, 2019

Presentation TCT 2019

Clinical Trial Updates: BEST-CLI, BASIL-2 and BASIL-3

Presenter: Matthew Menard

September 25, 2019

Presentation TCT 2019

Modern Outcomes for Rutherford 6 Patients: How to Avoid Primary Amputation

Presenter: Peter Schneider

September 25, 2019

Presentation TCT 2019

What Is Optimal Medical Therapy for CLI? Can We Move the Needle With Drugs Alone?

Presenter: Marc Bonaca

September 25, 2019

Presentation TCT 2019

Surgical Therapy: Indications for Surgery First for CLI

Presenter: Peter Schneider

September 25, 2019

Presentation TCT 2019

Featured Lecture: CLI Epidemiology and Clinical Burden

Presenter: Schuyler Jones

September 25, 2019

Presentation TCT 2019

CTO Crossing 5: Case Examples of Below-the-Ankle Access and Pedal Loop Reconstruction

Presenter: Osamu Iida

September 25, 2019

Presentation TVT 2019

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Presenter: Martin Leon

June 13, 2019

Presentation TVT 2019

The PARTNER 3 Low-Risk Randomized Trial

Presenter: Susheel Kodali

June 13, 2019

Advertisement

PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Industry Perspective on Drug-Eluting Technologies Guidance

FDA Perspective and Revised Guidance

New Data Regarding Drug-Eluting Technologies

An Unforeseen Setback: Summary Level Meta-Analysis Brings Practice Back to the 1990s.

Complex CLI Case Review 3: What Is Possible in the OBL?

Complex CLI Case Review 2: My Toughest Case From the Last Year

Complex CLI Case Review 1: My Best Case From the Last Year

CLI Diagnostics and Real-Time Guidance: What's New in 2019

Clinical Trial Updates: BTK Tacks, Scaffolds, and Drugs

Clinical Trial Updates: Deep Vein Arterialization

Clinical Trial Updates: BEST-CLI, BASIL-2 and BASIL-3

Modern Outcomes for Rutherford 6 Patients: How to Avoid Primary Amputation

What Is Optimal Medical Therapy for CLI? Can We Move the Needle With Drugs Alone?

Surgical Therapy: Indications for Surgery First for CLI

Featured Lecture: CLI Epidemiology and Clinical Burden

CTO Crossing 5: Case Examples of Below-the-Ankle Access and Pedal Loop Reconstruction

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

The PARTNER 3 Low-Risk Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content